Drug Shortage Report for ALTACE HCT

Last updated on 2020-10-28 History
Report ID 106252
Drug Identification Number 02283174
Brand name ALTACE HCT
Common or Proper name ALTACE HCT
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) HYDROCHLOROTHIAZIDE RAMIPRIL
Strength(s) 25.0MG 5.0MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28 tabs
ATC code C09BA
ATC description ACE INHIBITORS, COMBINATIONS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-24
Estimated end date
Actual end date 2020-09-29
Shortage status Resolved
Updated date 2020-10-28
Company comments artwork related
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v32 2020-10-28 French Compare
v31 2020-10-28 English Compare
v30 2020-10-21 French Compare
v29 2020-10-21 English Compare
v28 2020-09-23 French Compare
v27 2020-09-23 English Compare
v26 2020-09-10 French Compare
v25 2020-09-10 English Compare
v24 2020-08-13 French Compare
v23 2020-08-13 English Compare
v22 2020-07-29 French Compare
v21 2020-07-29 English Compare
v20 2020-07-27 French Compare
v19 2020-07-27 English Compare
v18 2020-07-02 French Compare
v17 2020-07-02 English Compare
v16 2020-06-03 French Compare
v15 2020-06-03 English Compare
v14 2020-05-28 French Compare
v13 2020-05-28 English Compare

Showing 1 to 20 of 32